Stryker Corp.07.10.18
Stryker Corporation announced today that David K. Floyd, Group President, Orthopaedics has notified the company of his intent to retire on June 30, 2019. Until this date, Floyd will serve as Group President and Advisor to the CEO and will assist with transitioning his responsibilities to our newly appointed leaders while also contributing to strategic growth projects.
Floyd joined Stryker in 2012 after 25 successful years in the medical technology industry. David has served as a key member of Stryker's leadership team and enjoyed terrific success leading our Orthopaedics group.
"We are grateful for David's leadership and his many contributions to Stryker's success. His businesses consistently outgrew the market and David spearheaded several key acquisitions, including Mako. I wish David and his family all the very best in retirement," said Kevin A. Lobo, Chairman and CEO.
We are now shifting responsibility for all of our operating businesses and regions under Timothy J. Scannell who will be appointed president and COO effective August 1, 2018. In his new role, Tim will drive growth and operating leverage across all of Stryker's businesses while promoting globalization and collaboration across our commercial units.
"Over his 28 years at Stryker, Tim has built an excellent track record of high performance and people development. I look forward to working closely with him and the rest of the Stryker leadership team to take Stryker to new heights," said Lobo.
Scannell began his career with Stryker's Endoscopy business in 1990 where he served in sales and marketing leadership roles. He then took on roles of increased responsibility spanning many of our businesses and has served as a Group President for nearly a decade, most recently overseeing MedSurg & Neurotechnology.
Within the new commercial leadership structure, Stryker will have two new Group Presidents. J. Andrew Pierce has been appointed Group President of MedSurg and Spencer S. Stiles has been appointed Group President of Instruments, Neurotechnology, and Spine. Pierce and Stiles have delivered strong performance over time in their lengthy Stryker careers and will now be accountable for leading multiple businesses.
Floyd joined Stryker in 2012 after 25 successful years in the medical technology industry. David has served as a key member of Stryker's leadership team and enjoyed terrific success leading our Orthopaedics group.
"We are grateful for David's leadership and his many contributions to Stryker's success. His businesses consistently outgrew the market and David spearheaded several key acquisitions, including Mako. I wish David and his family all the very best in retirement," said Kevin A. Lobo, Chairman and CEO.
We are now shifting responsibility for all of our operating businesses and regions under Timothy J. Scannell who will be appointed president and COO effective August 1, 2018. In his new role, Tim will drive growth and operating leverage across all of Stryker's businesses while promoting globalization and collaboration across our commercial units.
"Over his 28 years at Stryker, Tim has built an excellent track record of high performance and people development. I look forward to working closely with him and the rest of the Stryker leadership team to take Stryker to new heights," said Lobo.
Scannell began his career with Stryker's Endoscopy business in 1990 where he served in sales and marketing leadership roles. He then took on roles of increased responsibility spanning many of our businesses and has served as a Group President for nearly a decade, most recently overseeing MedSurg & Neurotechnology.
Within the new commercial leadership structure, Stryker will have two new Group Presidents. J. Andrew Pierce has been appointed Group President of MedSurg and Spencer S. Stiles has been appointed Group President of Instruments, Neurotechnology, and Spine. Pierce and Stiles have delivered strong performance over time in their lengthy Stryker careers and will now be accountable for leading multiple businesses.